Literature DB >> 1262041

Human colonic adenocarcinoma cells. I. Establishment and description of a new line.

B H Tom, L P Rutzky, M M Jakstys, R Oyasu, C I Kaye, B D Kahan.   

Abstract

A series of human colonic epithelial cell lines have been cultured from a single patient: LS-180 the original adenocarcinoma, LS-174T a trypsinized variant, and normal colonic tissue. The malignant cells, 20 to 40, mum in diameter and oval to polygonal, exhibited characteristics of normal colonic mucosal cells, namely, abundant microvilli prominent in secretory cells, and the presence of intracytoplasmic mucin vacuoles. The cultured adenocarcinoma cells, but not normal, demonstrated neoplastic properties by producing high levels of carcinoembryonic antigen (CEA) and by the ability to be propagated in hamster cheek pouches and in immunodeprived mice. The CEA production by the newly established line LS-180 released 900 times more CEA per cell into the culture medium and bore 30 times more cell-associated material than the established line, HT-29. These cell lines may permit detection of distinctive chemical, physiological, pharmacologic, and immunologic characteristics of neoplastic colonic cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262041     DOI: 10.1007/BF02796440

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  27 in total

Review 1.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

Review 2.  Possibilities and problems of immunologic intervention in cancer.

Authors:  R T Smith
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

3.  Adhesion of culture cells to their substratum.

Authors:  J P Revel; P Hoch; D Ho
Journal:  Exp Cell Res       Date:  1974-03-15       Impact factor: 3.905

4.  Immunodiagnostic test for transplant rejection.

Authors:  B D Kahan; B H Tom; K K Mittal; J J Bergan
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

Review 5.  Chromosomal abnormalities in human neoplasia.

Authors:  A A Sandberg; D K Hossfeld
Journal:  Annu Rev Med       Date:  1970       Impact factor: 13.739

6.  Anti-tumor activity in human serum: antibodies detecting blood-group-A-like antigen on the surface of tumor cells in culture.

Authors:  E T Bloom; J L Fahey; I A Peterson; G Geering; M Bernhard; G Trempe
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

7.  Position of the carcinoembryonic antigen of the human digestive system in ultrastructure of tumor cell surface.

Authors:  P Gold; J Krupey; H Ansari
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

8.  Characteristics of the leucocyte-aggregation assay for cell-mediated immunity.

Authors:  B H Tom; L O Huang; M M Jakstys; B D Kahan
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

9.  Enzyme activity in invasive tumors of human breast and colon.

Authors:  H B Bosmann; T C Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Prostaglandin E (PGE) control of cell proliferation in vitro: characteristics of HT-29.

Authors:  D R Thomas; G W Philpott; B M Jaffe
Journal:  J Surg Res       Date:  1974-05       Impact factor: 2.192

View more
  122 in total

1.  Evolutionary history and functional characterization of the amphibian xenosensor CAR.

Authors:  Marianne Mathäs; Oliver Burk; Huan Qiu; Christian Nusshag; Ute Gödtel-Armbrust; Dorothea Baranyai; Shiwei Deng; Kristin Römer; Dieudonné Nem; Björn Windshügel; Leszek Wojnowski
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.

Authors:  Elke Störmer; Lisa L von Moltke; Michael D Perloff; David J Greenblatt
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

3.  Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.

Authors:  Diane E Milenic; Karen J Wong; Kwamena E Baidoo; Tapan K Nayak; Celeste A S Regino; Kayhan Garmestani; Martin W Brechbiel
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

4.  Expression of two cytochromes P450 involved in carcinogen activation in a human colon cell line.

Authors:  T B White; D K Hammond; H Vásquez; H W Strobel
Journal:  Mol Cell Biochem       Date:  1991-03-27       Impact factor: 3.396

5.  Fibroblastlike primary cells from human colon adenocarcinoma explants: collagen biosynthesis.

Authors:  J Turnay; N Olmo; J G Gavilanes; M A Lizarbe
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

6.  Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.

Authors:  Diane E Milenic; Kayhan Garmestani; Erik D Brady; Kwamena E Baidoo; Paul S Albert; Karen J Wong; Joseph Flynn; Martin W Brechbiel
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

7.  Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications.

Authors:  Diane E Milenic; Karen J Wong; Kwamena E Baidoo; Geoffrey L Ray; Kayhan Garmestani; Mark Williams; Martin W Brechbiel
Journal:  Cancer Biother Radiopharm       Date:  2008-10       Impact factor: 3.099

8.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

9.  Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines.

Authors:  A R Kinsella; G C Lepts; C L Hill; M Jones
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

10.  The human lysozyme promoter directs reporter gene expression to activated myelomonocytic cells in transgenic mice.

Authors:  S Clarke; D R Greaves; L P Chung; P Tree; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.